共 132 条
[1]
Torre LA(2016)Global cancer incidence and mortality rates and trends—an update Cancer Epidemiol Biomarkers Prev 25 16-27
[2]
Siegel RL(2017)Incidence of hepatocellular carcinoma in all 50 united states, from 2000 through 2012 Gastroenterology. 152 812-820.e5
[3]
Ward EM(2016)Future of hepatocellular carcinoma incidence in the united states forecast through 2030 J Clin Oncol. 34 1787-1794
[4]
Jemal A(2011)Management of hepatocellular carcinoma: an update Hepatology. 53 1020-1022
[5]
White DL(2021)Medicare/Medicaid Insurance, rurality, and Black race associated with provision of hepatocellular carcinoma treatment and survival J Natl Compr Canc Netw 19 1-9
[6]
Thrift AP(2016)hospital volume and survival after hepatocellular carcinoma diagnosis Am J Gastroenterol 111 967-975
[7]
Kanwal F(2013)Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States Aliment Pharmacol Ther 38 703-712
[8]
Davila J(2021)Racial disparities in hepatocellular carcinoma Cancer 127 1369-1370
[9]
El-Serag HB(2018)The effects of medicaid expansion under the ACA: a systematic review Health Aff (Millwood) 37 944-950
[10]
Petrick JL(2017)What is Medicaid? More than meets the eye JAMA 318 695-696